Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 3Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 772Leukemia 596Leukemia, Lymphocytic, Chronic, B-Cell 535Precursor Cell Lymphoblastic Leukemia-Lymphoma 485Myelodysplastic Syndromes 408Lymphoma, Non-Hodgkin 265Lymphoma 265Hematologic Neoplasms 251Leukemia, Myelogenous, Chronic, BCR-ABL Positive 232Multiple Myeloma 199Hodgkin Disease 193Lymphoma, Follicular 181Lymphoma, Mantle-Cell 179Lymphoma, B-Cell, Marginal Zone 156Lymphoma, Large B-Cell, Diffuse 155Burkitt Lymphoma 155Recurrence 149Leukemia, Myelomonocytic, Chronic 139Congenital Abnormalities 131Myeloproliferative Disorders 122Waldenstrom Macroglobulinemia 106Neoplasms 97Leukemia, Myeloid, Chronic-Phase 97Lymphoma, Large-Cell, Immunoblastic 91Primary Myelofibrosis 88Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 81Blast Crisis 80Leukemia, Myeloid, Accelerated Phase 74Anemia, Refractory, with Excess of Blasts 72Lymphoma, T-Cell, Cutaneous 68

Interventions

nilotinib 1Imatinib Mesylate 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Hypereosinophilic Syndrome × Other hematologic neoplasm × Clear all
NCT00255346 2025-12-30

Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)

M.D. Anderson Cancer Center

Phase 2 Completed
68 enrolled 13 charts
MyeloidOther hematologic neoplasm

Leukemia, Mastocytosis, Myelodysplastic Syndromes, Polycythemia Vera, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hypereosinophilic Syndrome, Primary Myelofibrosis

NCT00038675 2022-01-04

Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate

M.D. Anderson Cancer Center

Phase NA Completed
125 enrolled 9 charts
MyeloidOther hematologic neoplasm

Leukemia, Mastocytosis, Polycythemia Vera, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myelomonocytic, Chronic, Hypereosinophilic Syndrome

NCT00109707 2021-06-29

A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

Novartis

Phase 1/2 Completed
507 enrolled 16 charts
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hypereosinophilic Syndrome, Mastocytosis, Systemic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡